Exposure to cigarette smoke does not decrease the neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice

Epidemiological surveys have repeatedly shown that idiopathic Parkinson's disease (PD) occurs less frequently in persons who have smoked cigarettes for many years than among age-matched non-smokers. Since PD might be caused by neurotoxins chemically similar to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), we explored the possible protective effect of repeated exposure to cigarette smoke against MPTP neurotoxicity in the C57 black mouse. Mice given MPTP and exposed to cigarette smoke suffered just as great a depletion of striatal dopamine as did mice treated only with MPTP. We discovered also that different lots of C57 black mice obtained from a single supplier can have markedly different sensitivities to MPTP.

[1]  H. Freimuth,et al.  Carbon Monoxide in Blood: a Simple and Rapid Estimation , 1943 .

[2]  E. Diamond,et al.  Epidemiologic studies of Parkinson's disease. I. Smoking and Parkinson's disease: a survey and explanatory hypothesis. , 1971, American journal of epidemiology.

[3]  R. Heikkila Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources. , 1985, European journal of pharmacology.

[4]  R. Godwin-Austen,et al.  Smoking and Parkinson's disease. , 1982, Journal of neurology, neurosurgery, and psychiatry.

[5]  D. Godin,et al.  Parkinson's disease: A disorder due to nigral glutathione deficiency? , 1982, Neuroscience Letters.

[6]  R. Marttila,et al.  Smoking and Parkinson's disease , 1980, Acta neurologica Scandinavica.

[7]  R. Clavier,et al.  Effects of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and its metabolite, N-methyl-4-phenylpyridinium ion, on dopaminergic nigrostriatal neurons in the mouse , 1985, Neuroscience Letters.

[8]  M. Nefzger,et al.  A retrospective study of smoking in Parkinson's disease. , 1968, American journal of epidemiology.

[9]  I. I. Kessler,et al.  EPIDEMIOLOGIC STUDIES OF PARKINSON'S DISEASE: III. A COMMUNITY-BASED SURVEY , 1972 .

[10]  L. Golbe,et al.  Smoking and Parkinson's disease. Search for a dose-response relationship. , 1986, Archives of neurology.

[11]  R. Baumann,et al.  Cigarette smoking and Parkinson disease , 1980, Neurology.

[12]  K. Jellinger,et al.  Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. , 1973, Journal of the neurological sciences.

[13]  S J Kish,et al.  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) does not destroy nigrostriatal neurons in the scorbutic guinea pig. , 1985, Life sciences.

[14]  J. Langston,et al.  MPTP and parkinson's disease , 1985, Trends in Neurosciences.